Congruence between preferred and actual place of care and death among Danish cancer patients.

Palliat Med

Research Unit for General Practice and Department of Family Medicine, Aarhus University, School of Public Health, Denmark.

Published: February 2013

Background: Meeting patient's preferences is an important outcome in palliative care. No Scandinavian study has reported systematically collected preferences from patients regarding place of care (POC) and place of death (POD). The extent of possible incongruence between patients' preferences and reality remains unknown.

Aim: The aim of this study was to describe patients' preferred POC and POD and changes in preferences over time and to evaluate congruence between preferences and reality. Furthermore, the aim was to search for predictive factors regarding patients' wishes and fulfilment of these.

Method: This is a prospective interview and questionnaire study.

Setting/participants: The study was conducted in the former Aarhus County, Denmark and 96 end-stage cancer patients participated.

Results: Of the patients, who stated a preference, 84% preferred home care and 71% preferred home death. A positive association between living with a partner and both wishing for home care and home death was observed (prevalence ratio (PR): 1.66 (95% confidence intervals (CI): 1.07, 2.58), p = 0.02 and PR: 2.33 (95% CI: 1.14, 4.77), p = 0.02, respectively). Marked changes in preferences were observed. Overall, preferences were met for approximately half of the patients, although kappa values were low (κ=0.132 for POC and κ=0.034 for POD).We found a significant association between being cared for in the preferred place and having contact with a palliative care team (PR: 2.01 (95% CI: 1.02, 3.98), p = 0.045).

Conclusion: Regular discussions with patients on this subject are needed. Social and professional support is of importance in meeting patients' preferences. Larger scaled studies and research focusing on meeting patients' preferences are needed.

Download full-text PDF

Source
http://dx.doi.org/10.1177/0269216312438468DOI Listing

Publication Analysis

Top Keywords

patients' preferences
12
preferences
9
place care
8
care death
8
cancer patients
8
palliative care
8
preferences reality
8
changes preferences
8
meeting patients'
8
care
6

Similar Publications

Traumatic retroclival hematoma resulting in abducens nerve palsy: illustrative case.

J Neurosurg Case Lessons

January 2025

Department of Neurological Surgery, Mayo Clinic, Rochester, Minnesota.

Background: Posttraumatic retroclival hematomas are rare pathologies among pediatric patients and can result in cranial nerve palsies. The authors sought to survey the literature and characterize the risk factors, treatment considerations, and overall outcomes for pediatric patients experiencing posttraumatic retroclival hematomas.

Observations: A search of the Ovid Embase, Scopus, PubMed, and Web of Science databases from January 1986 to May 2024 was performed following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.

View Article and Find Full Text PDF

Digital Transformation of Rheumatology Care in Germany: Cross-Sectional National Survey.

J Med Internet Res

January 2025

Center for Health Services Research, Faculty of Health Sciences Brandenburg, Brandenburg Medical School Theodor Fontane, Rüdersdorf bei Berlin, Germany.

Background: In recent years, health care has undergone a rapid and unprecedented digital transformation. In many fields of specialty care, such as rheumatology, this shift is driven by the growing number of patients and limited resources, leading to increased use of digital health technologies (DHTs) to maintain high-quality clinical care. Previous studies examined user acceptance of individual DHTs in rheumatology, such as telemedicine, video consultations, and mHealth.

View Article and Find Full Text PDF

Purpose: Datopotamab deruxtecan (Dato-DXd) is a trophoblast cell-surface antigen-2-directed antibody-drug conjugate with a highly potent topoisomerase I inhibitor payload. The TROPION-Lung05 phase II trial (ClinicalTrials.gov identifier: NCT04484142) evaluated the safety and clinical activity of Dato-DXd in patients with advanced/metastatic non-small cell lung cancer (NSCLC) with actionable genomic alterations progressing on or after targeted therapy and platinum-based chemotherapy.

View Article and Find Full Text PDF

Background: Radiofrequency microneedling (RFM) is a potential treatment for primary hyperhidrosis. However, its efficacy is unclear, and treatment parameters and outcomes vary across studies.

Objective: To understand the effect of RFM on treating primary hyperhidrosis, as measured by changes in the Hyperhidrosis Disease Severity Score (HDSS) before and after treatment, and to clearly define treatment settings most likely to optimize results.

View Article and Find Full Text PDF

Patients often use Google for their medical questions. With the emergence of artificial intelligence large language models, such as ChatGPT, patients may turn to such technologies as an alternative source of medical information. This study investigates the safety, accuracy, and comprehensiveness of medical responses provided by ChatGPT in comparison to Google for common questions about burn injuries and their management.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!